Comments

cbdMD

Q: What sector and industry does cbdMD (YCBD) operate in?

cbdMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.

YCBDAMEX

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.3600

-0.01-2.70%

At close: -

$0.3600

0.000.00%

After Hours: Dec 20, 5:03 PM EDT

Q4 2024 Earnings were released on Wed Dec 18th, after the market close

The most recent conference call was at 16:20 PM, 4 days ago

cbdMD (YCBD) Forecast

News Earnings cbdMD (YCBD) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

cbdMD (AMEX:YCBD) Stock Quotes, Forecast and News Summary

cbdMD Stock (AMEX: YCBD) stock price, news, charts, stock research, profile.

Open	$0.34
Close	$0.36
Volume / Avg.	175.27K / 343.72K
Day Range	$0.32 - $0.37
52 Wk Range	0.31 - 1.73
Market Cap	$1.61M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	38
Short Interest	4.74%
Days to Cover	2.26

Recent News

Why Intuitive Surgical Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

cbdMD Reduces Operating Loss, Reports Positive Net Income For Q3 And 15% YoY Drop In Net Sales

cbdMD, Inc. (NYSE: YCBD), an operator of the leading CBD brands cbdMD and Paw CBD, along with its new functional mushroom brand ATRx Labs announced on Wednesday its financial results for the third quarter of fiscal 2024 ending June 30, 2024. Year-over-year, operational losses improved markedly, shrinking from $1.8 million in the third quarter of fiscal 2023 to $0.38 million in the third quarter of fiscal 2024, the company highlighted in the press release. Ronan Kennedy, the company's CEO and CFO, praised the financial results.

Jelena Martinovic

IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now

Medical cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30, 2024, on Wednesday, Aug. 14, 2024. cbdMD, Inc. (NYSE: YCBD) said it will host a conference call at 4:20 pm Eastern Time, on Wednesday, Aug. 14, 2024, to discuss the company's June 30, 2024 third quarter of fiscal 2024 financial results and business progress. Canadian cannabis producer and distributor Entourage Health Corp. (TSX-V: ENTG) (OTCQX: ETRGF) (FSE:4WE) its second quarter 2024 financial results will be released after market close on Monday, Aug. 26, 2024. The company will host a conference call to discuss the results and provide an operational update and recap of achievements on Tuesday, Aug. 27, 2024. Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. will report earnings results for its third quarter fiscal 2024 ended June 30, 2024, on Tuesday, Aug. 13, 2024, before market open. The company will host a conference call to discuss its results with details the same day at 8:00 am Eastern Time.

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$0.34
Close	$0.36
Volume / Avg.	175.27K / 343.72K
Day Range	$0.32 - $0.37
52 Wk Range	0.31 - 1.73
Market Cap	$1.61M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	38
Short Interest	4.74%
Days to Cover	2.26

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy cbdMD (YCBD) stock?

You can purchase shares of cbdMD (AMEX:YCBD) through any online brokerage.

View our list of the best stock brokerages

Who are cbdMD (YCBD) competitors?

Other companies in cbdMD’s space includes: Processa Pharma (NASDAQ:PCSA), NovaBay Pharmaceuticals (AMEX:NBY), Titan Pharma (NASDAQ:TTNP), 60 Degrees (NASDAQ:SXTP) and Akanda (NASDAQ:AKAN).

What is the forecast, or price target, for cbdMD (YCBD) stock?

cbdMD has a consensus price target of $3.00.

What is the current price for cbdMD (YCBD)?

The stock price for cbdMD (AMEX: YCBD) is $0.36 last updated December 20, 2024 at 8:00 PM EST.

Does cbdMD (YCBD) pay a dividend?

There are no upcoming dividends for cbdMD.

When is cbdMD (AMEX:YCBD) reporting earnings?

cbdMD’s Q1 earnings are confirmed for Tuesday, February 11, 2025.

Is cbdMD (YCBD) going to split?

There is no upcoming split for cbdMD.

What sector and industry does cbdMD (YCBD) operate in?

cbdMD is in the Health Care sector and Pharmaceuticals industry. They are listed on the AMEX.